Together, TXNIP, EGR1, and IGFBP5 served as potential biomarkers for AD diagnosis reflecting different pathogenetic pathways involved in the development of AD, which may be due to the complicated and multiple pathophysiological manifestations of AD. The gene discussed is IGFBP5; the disease is Alzheimer disease.